Cognitive Enhancement Therapy in Substance Misusing Schizophrenia: Results of an 18-Month Feasibility Trial

Schizophrenia Research - Netherlands
doi 10.1016/j.schres.2014.11.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study

Journal of Dual Diagnosis
PsychiatryMental Health
2016English

Cognitive-Behavioural Therapy and Motivational Intervention for Schizophrenia and Substance Misuse: 18-Month Outcomes of a Randomised Controlled Trial

British Journal of Psychiatry
MedicinePsychiatryMental Health
2003English

Cognitive Enhancement in Schizophrenia

Psychiatric Clinics of North America
PsychiatryMental Health
2012English

Obesity Reduction Black Intervention Trial (ORBIT): 18-Month Results

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2010English

Cognitive Remediation Therapy in Schizophrenia: Randomised Controlled Trial

British Journal of Psychiatry
MedicinePsychiatryMental Health
2007English

Manual-Assisted Cognitive Therapy for Self-Harm in Personality Disorder and Substance Misuse: A Feasibility Trial

The Psychiatric Bulletin
2014English

Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia

Archives of General Psychiatry
2010English

A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2012English

Cognitive Enhancement in Schizophrenia With Pharmacological Interventions

Annals of General Psychiatry
PsychiatryMental Health
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy